Pharmabiz4h
Zydus enters agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR to its template formulary
Zydus enters agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR to its template formulary: Our Bureau, Mumbai Tuesday, January 7, 2025, 17:15 Hrs [IST] Zydus L ...
Pharmabiz4h
SunAct Cancer Institute ties up with Singapore’s CytoMed for phase 2 clinical trials on innovative Gamma Delta T-cell cancer therapy in India
Our Bureau, Mumbai Tuesday, January 7, 2025, 16:45 Hrs [IST] ...
Pharmabiz4h
JCR Pharma & Modalis validate initial proof of concept in a joint research programme for development of a novel gene therapy for a CNS disease
JCR Pharma & Modalis validate initial proof of concept in a joint research programme for development of a novel gene therapy for a CNS disease: Hyogo, Japan Tuesday, January 7, 20 ...
Pharmabiz3h
Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection
Acurx Pharma receives positive regulatory guidance from EMA for ibezapolstat phase 3 programme for C. difficile infection: Staten Island, New York Tuesday, January 7, 2025, 18:00 ...
Pharmabiz6h
eMBR Genomics partners with Axio BioPharma to make MKLP1 Pro antibodies commercially available
MBR Genomics partners with Axio BioPharma to make MKLP1 Pro antibodies commercially available: Madison, Wisconsin Tuesday, January 7, 2025, 15:00 Hrs [IST] In a milestone for cel ...
Pharmabiz13h
Indian pharma notes revised Schedule M extension signals key step to avoid closure of units
Indian pharma notes revised Schedule M extension signals key step to avoid closure of units: Nandita Vijayasimha, Bengaluru Tuesday, January 7, 2025, 08:00 Hrs [IST] Indian pharma ...
Pharmabiz9h
Biotech Showcase 2025 is set to convene in San Francisco for Biotech Investor Conference
Biotech Showcase 2025 is set to convene in San Francisco for Biotech Investor Conference: Our Bureau, Mumbai Tuesday, January 7, 2025, 12:00 Hrs [IST] Biotech Showcase 2025, an ex ...
Pharmabiz12h
Astellas Pharma’s Vyloy receives China NMPA approval for first-line treatment of advanced gastric or GEJ adenocarcinoma
Astellas Pharma’s Vyloy receives China NMPA approval for first-line treatment of advanced gastric or GEJ adenocarcinoma: Tokyo Tuesday, January 7, 2025, 09:00 Hrs [IST] Astellas ...
Pharmabiz11h
CHOP researchers develop new tool with potential to advance precision medicine treatment for cancer
CHOP researchers develop new tool with potential to advance precision medicine treatment for cancer: Philadelphia, Pennsylvania Tuesday, January 7, 2025, 10:00 Hrs [IST] Researche ...
Pharmabiz10h
Sun Pharma inaugurates Training-Cum-Production Centre to empower women in Jammu
Sun Pharma inaugurates Training-Cum-Production Centre to empower women in Jammu: Our Bureau, Mumbai Tuesday, January 7, 2025, 11:30 Hrs [IST] As a part of its CSR vision to bring ...
Pharmabiz10h
CRIUS Group adopts 100%AI-based project implementation
Our Bureau, Bengaluru Tuesday, January 7, 2025, 11:30 Hrs [IST] CRIUS Group has emerged as India’s first contract manufac ...
Pharmabiz13h
Indian healthcare sees medical networking as catalyst for quality services in remote regions
Indian healthcare sees medical networking as catalyst for quality services in remote regions: Nandita Vijayasimha, Bengaluru Tuesday, January 7, 2025, 08:00 Hrs [IST] The Indian h ...